Form 4: Cooper Companies Executive's Future Stock Transactions

Gerard H. Warner III, President of CooperVision, Inc., reported future scheduled acquisitions and dispositions of Cooper Companies common stock and Restricted Stock Units.

Summary

• Gerard H. Warner III, President of CooperVision, Inc., reported scheduled transactions for Cooper Companies, Inc. common stock and Restricted Stock Units (RSUs).
• On January 8, 2026, Mr. Warner is scheduled to acquire a total of 11,518 shares of common stock through the vesting and conversion of RSUs.
• These acquisitions include 2,652, 3,154, 1,232, 2,940, and 1,540 shares, all at an exercise price of $0.00.
• Concurrently, Mr. Warner is scheduled to dispose of a total of 5,985 shares of common stock at a price of $83.13 per share.
• These dispositions are marked with transaction code "F," indicating they are likely for the payment of exercise price or tax liability related to the RSU vesting.
• Following these scheduled transactions, Mr. Warner will directly beneficially own 23,852 shares of common stock.
• Several RSU awards have future vesting schedules extending through January 8, 2029, subject to continued service.

Sentiment

Score: 6

Explanation: The filing indicates routine executive equity compensation activity, with significant share acquisitions through RSU vesting, partially offset by tax-related sales. This is generally neutral to slightly positive as it shows continued executive alignment and retention, without any large, unprompted sales.

Positives

• The executive is acquiring a significant number of shares (11,518) through RSU vesting, indicating continued long-term incentive alignment with shareholder interests.
• The acquisitions are at a $0.00 exercise price, reflecting the value of previously granted equity compensation.
• The executive retains a substantial direct beneficial ownership of 23,852 common shares after the reported transactions.

Negatives

• A portion of the acquired shares (5,985 shares) are being disposed of to cover tax liabilities or exercise costs, which is a common practice but reduces the immediate increase in direct ownership.
• The disposition price of $83.13 per share reflects the market value at the time of the tax-related sale.

Future Outlook

The filing details future scheduled equity transactions for an executive, including RSU vesting events extending through January 8, 2029, subject to continued service. This indicates a long-term retention strategy for key management.

Industry Context

This Form 4 filing reflects routine equity compensation practices common across publicly traded companies, particularly in the healthcare and medical device sectors. The use of Restricted Stock Units (RSUs) with multi-year vesting schedules is a standard mechanism to align executive incentives with long-term company performance and ensure executive retention. The tax-related sales are also a typical component of RSU vesting events.

Stakeholder Impact

• Shareholders: The transactions demonstrate continued executive ownership and alignment with shareholder interests through long-term equity incentives. The tax-related sales are a common and expected part of RSU vesting.
• Employees: The filing highlights the company's use of equity compensation to incentivize and retain key executives.

Next Steps

• Future vesting of 2,652 shares on January 8, 2027, from a 4-year RSU award.
• Future vesting of 2,940 shares on January 8, 2027, from a 4-year RSU award.
• Future vesting of 3,154 shares on January 8, 2027, from a 4-year RSU award.
• Future vesting of 2,936 shares on January 8, 2028, from a 4-year RSU award.
• Future vesting of 3,154 shares on January 8, 2028, from a 4-year RSU award.
• Future vesting of 3,154 shares on January 8, 2029, from a 4-year RSU award.

Key Dates

Recommendation

This Form 4 details routine executive equity compensation, including RSU vesting and associated tax-related sales. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The executive's continued ownership and future vesting schedules suggest ongoing alignment with the company's long-term prospects, supporting a 'hold' position for existing investors.

Keywords

Cooper Companies, COO, Gerard H. Warner III, CooperVision, SEC Form 4, Insider Trading, Restricted Stock Units, RSU vesting, Stock transactions, Equity compensation, Officer transactions